Nancy Thornberry Denali Therapeutics Inc. (DNLI) insider trading activity

Nancy Thornberry is Director of Denali Therapeutics Inc.. Currently has a direct ownership of 18,680 shares of DNLI, which is worth approximately $457,660. The most recent transaction as insider was on May 31, 2024, when has been sold 5,967 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 18.7K

0% 3M change

46.94% 12M change

Total Value Held $457,660

Nancy Thornberry Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 31 2024	BUY Grant, award, or other acquisition	-	5,967 Added 24.21%	18,680 Common Stock
Jun 01 2023	BUY Grant, award, or other acquisition	-	4,216 Added 24.9%	12,713 Common Stock
Jun 02 2022	BUY Grant, award, or other acquisition	-	5,986 Added 41.33%	8,497 Common Stock
Jan 08 2022	BUY Grant, award, or other acquisition	-	627 Added 19.98%	2,511 Common Stock

Also insider at

SDGR

Schrodinger, Inc. Healthcare

Director

VRTX

VERTEX PHARMACEUTICALS INC Healthcare

Director